Get started
Work

Supplementary Figure S3 from Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure S3. Tumor PMN-MDSC do not inhibit KIL effector function through PD-L1, arginase or NOS
DOI: 10.1158/1078-0432.22478696.v1
Authors: Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz, Angel P. Huynh, Nicole C. Schmitt, Jay Friedman, Lucas A. Horn, Claudia Palena, Jeffrey Schlom, Dean Y. Maeda, John A. Zebala, Paul E. Clavijo, Clint Allen
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4361938571
Cites:
Cited by:
Related to: 10